Filament Health Corp.
FLHLFOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$26179
P/E Ratio—
52W High$0.0201
52W Low$0.0001
Filament Health Corp. (FLHLF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
FLHLF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 19, 2026EPS Actual
-$0.00
Revenue
$0.00B
Est. $0.00B · -34.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 19, 2026
After Market Close
▼ Miss Revenue
FLHLF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2026 | May 19, 2026 | — | -$0.00 | — | $0.00B | $0.00B | -34.5% |
| ◌ Q1 FY2026 | Mar 27, 2026 | — | — | — | — | — | — |
| — Q3 FY2025 | Sep 30, 2025 | — | -$0.00 | — | $0.00B | — | — |
| ◌ Q3 FY2025 | Aug 8, 2025 | — | — | — | — | — | — |
| — Q4 FY2024 | Dec 31, 2024 | — | -$0.01 | — | $0.00B | $0.00B | +442.9% |
| — Q3 FY2024 | Sep 30, 2024 | — | -$0.00 | — | $0.00B | $0.00B | -87.4% |
| — Q2 FY2024 | Jun 29, 2024 | — | -$0.00 | — | $0.00B | $0.00B | -45.1% |
| — Q1 FY2024 | Mar 30, 2024 | — | -$0.00 | — | $0.00B | $0.00B | +173.3% |
Q2 FY2026
May 19, 2026
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2026
Mar 27, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Sep 30, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2025
Aug 8, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Dec 31, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2024
Sep 30, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
Jun 29, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2024
Mar 30, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2029 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 19, 2026 | — | $0.00 | — | — |
| — Q3 FY2025 | Sep 30, 2025 | — | $0.02 | $0.02 | +0.00% |
| — Q4 FY2024 | Dec 31, 2024 | — | $0.04 | $0.03 | -22.36% |
| — Q3 FY2024 | Sep 30, 2024 | — | $0.04 | $0.04 | -18.02% |
| — Q2 FY2024 | Jun 29, 2024 | — | $0.03 | $0.02 | -36.72% |
| — Q1 FY2024 | Mar 30, 2024 | — | $0.03 | $0.04 | +15.20% |
| — Q4 FY2023 | Dec 30, 2023 | — | $0.05 | $0.07 | +22.00% |
| — Q3 FY2023 | Sep 30, 2023 | — | $0.12 | $0.12 | -0.48% |
Q2 FY2026—
Report Date
May 19, 2026
EPS Beat/Miss
—
Price Before
$0.00
Price After
—
Q3 FY2025+0.00%
Report Date
Sep 30, 2025
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q4 FY2024-22.36%
Report Date
Dec 31, 2024
EPS Beat/Miss
—
Price Before
$0.04
Price After
$0.03
Q3 FY2024-18.02%
Report Date
Sep 30, 2024
EPS Beat/Miss
—
Price Before
$0.04
Price After
$0.04
Q2 FY2024-36.72%
Report Date
Jun 29, 2024
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.02
Q1 FY2024+15.20%
Report Date
Mar 30, 2024
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.04
Q4 FY2023+22.00%
Report Date
Dec 30, 2023
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.07
Q3 FY2023-0.48%
Report Date
Sep 30, 2023
EPS Beat/Miss
—
Price Before
$0.12
Price After
$0.12
Beat Rate0 / 8 quarters
Largest Move-36.72% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: FLHLF ends December
Filament Health Corp. (FLHLF) most recently reported earnings on May 19, 2026 for Q2 FY2026, posting EPS of $-0.00 (in line with the analyst consensus of —). The next FLHLF earnings date is expected around September 1, 2026.
Each quarter, investors track FLHLF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. FLHLF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
FLHLF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
FLHLF earnings · 4 questionsFilament Health Corp.'s next earnings report is expected around September 1, 2026. FLHLF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; FLHLF historically reports after market close (AMC).
FLHLF earnings datewhen is FLHLF earningsFLHLF next earnings datewhen does FLHLF report earningsFLHLF earnings calendar
▸ Source: FMP · Filament Health Corp. SEC filings · US GAAP · Filament Health Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026